EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The BRCA1 c.4096+1G>A Is a Founder Variant Which Originated in Ancient Times

Paolo Aretini iD, Silvano Presciuttini, Aldo Pastore, Alvaro Galli iD, Sara Panepinto, Mariella Tancredi, Matteo Ghilli iD, Chiara Guglielmi, Diletta Sidoti, Caterina Congregati, Maria Adelaide Caligo iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Paolo Aretini und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Pisana per la Scienza, San Giuliano Terme, 56017 Pisa, Italy. Hauptthemen laut MEDLINE: BRCA1 Protein, Breast Neoplasms, Ovarian Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Toscana, Progetto Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Approximately 30–50% of hereditary breast and ovarian cancer (HBOC) is due to the presence of germline pathogenic variants in the BRCA1 (OMIM 113705) and BRCA2 (OMIM 600185) onco-suppressor genes, which are involved in DNA damage response. Women who carry pathogenic BRCA1 variants are particularly likely to develop breast cancer (BC) and ovarian cancer (OC), with a 45–79 percent and 39–48 percent chance, respectively. The BRCA1 c.4096+1G>A variant has been frequently ascertained in Tuscany, Italy, and it has also been detected in other Italian regions and other countries. Its pathogenetic status has been repeatedly changed from a variant of uncertain significance, to pathogenic, to likely pathogenic. In our study, 48 subjects (38 of whom are carriers) from 27 families were genotyped with the Illumina OncoArray Infinium platform (533,531 SNPs); a 20 Mb region (24.6 cM) around BRCA1, including 4130 SNPs (21 inside BRCA1) was selected for haplotype analysis. We used a phylogenetic method to estimate the time to the most recent common ancestor (MRCA) of BRCA1 c.4096+1G>A founder pathogenic variant. This analysis suggests that the MRCA lived about 155 generations ago—around 3000 years ago.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinBreast NeoplasmsOvarian NeoplasmsFemaleHumansGenetic Predisposition to DiseaseGerm-Line MutationPhylogenyFounder Effect

Stichwörter der Autor:innen

BRCA1Italyfounder varianthereditary breast and ovarian cancerpathogenic variant

Substanzen

BRCA1 ProteinBRCA1 protein, human

Autor:innen und Institutionen

  • Fondazione Pisana per la Scienza, San Giuliano Terme, 56017 Pisa, Italy.
  • Dipartimento di Ricerca Traslazionale e Nuove Tecnologie in Medicina e Chirurgia, Università di Pisa, 56126 Pisa, Italy.
  • Laboratorio NEST, Scuola Normale Superiore, 56126 Pisa, Italy.
  • Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche (CNR), 56124 Pisa, Italy.
  • Laboratorio di Genetica Molecolare, Azienda Ospedaliera Universitaria Pisana, 56126 Pisa, Italy.
  • Breast Unit, Azienda Ospedaliera Universitaria Pisana, 56126 Pisa, Italy.

ORCID-Profile: Paolo Aretini, Alvaro Galli, Matteo Ghilli, Maria Adelaide Caligo

Förderung

  • Regione Toscana, Progetto Salute

Zitieren

APA

Aretini, P., Presciuttini, S., Pastore, A., Galli, A., Panepinto, S., Tancredi, M., Ghilli, M., Guglielmi, C., Sidoti, D., Congregati, C., & Caligo, M. A. (2023). The BRCA1 c.4096+1G>A Is a Founder Variant Which Originated in Ancient Times. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115507

Vancouver

Aretini P, Presciuttini S, Pastore A, Galli A, Panepinto S, Tancredi M, et al. The BRCA1 c.4096+1G>A Is a Founder Variant Which Originated in Ancient Times. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115507

BibTeX
@article{Aretini2023,
  author = {Aretini, Paolo and Presciuttini, Silvano and Pastore, Aldo and Galli, Alvaro and Panepinto, Sara and Tancredi, Mariella and Ghilli, Matteo and Guglielmi, Chiara and Sidoti, Diletta and Congregati, Caterina and Caligo, Maria Adelaide},
  title = {The BRCA1 c.4096+1G>A Is a Founder Variant Which Originated in Ancient Times},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115507}
}
Kostenlos starten →